• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

MYL:US

58.6200 USD 2.4500 4.36%

As of 20:10:00 ET on 11/26/2014.

Snapshot for Mylan Inc/PA (MYL)

Open: 56.8700 Day's Range: 56.7300 - 59.1200 Volume: 6,204,986
Previous Close: 56.1700 52wk Range: 41.2600 - 59.1200 1-Yr Rtn: +32.80%

Stock Chart for MYL

No chart data available.
  • MYL:US 58.6200
  • 1D
  • 1M
  • 1Y
56.1700
Interactive MYL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MYL

Current P/E Ratio (ttm) 20.0831
Estimated P/E(12/2014) 16.4617
Relative P/E vs. SPX 1.0941
Earnings Per Share (USD) (ttm) 2.9189
Est. EPS (USD) (12/2014) 3.5610
Est. PEG Ratio 1.2522
Market Cap (M USD) 21,939.92
Shares Outstanding (M) 374.27
30 Day Average Volume 3,862,399
Price/Book (mrq) 6.4748
Price/Sale (ttm) 2.9467
Dividend Indicated Gross Yield -%
Cash Dividend (USD) -
Dividend Ex-Date 07/17/2007
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MYL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MYL

Mylan Inc. is a global generic and specialty pharmaceuticals company. The Company operates an active pharmaceutical ingredient manufacturer and runs a specialty business focused on respiratory, allergy, and psychiatric therapies.

Robert J CouryChairmanRodney L PiattVice Chairman
Heather BreschChief Executive OfficerRajiv MalikPresident
More Company Profile & Key Executives for MYL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil